medigraphic.com
ISSN 0016-3813 (Print)

2014, Number 6

<< Back Next >>

Gac Med Mex 2014; 150 (6)

Deficient Prevention and Late Treatment of Diabetic Retinopathy in Mexico

Cervantes-Castañeda RA, Menchaca-Díaz R, Alfaro-Trujillo B, Guerrero-Gutiérrez M, Chayet-Berdowsky AS

Language: Spanish
References: 26
Page: 518-526
PDF size: 153.56 Kb.


ABSTRACT

Introduction: Retinopathy is a frequent complication of diabetes, causing visual impairment in 10% and blindness in 2% of diabetic patients. The aim of this study is to describe the clinical profile of diabetic patients in an ophthalmologic unit in Tijuana, México. Methods: Retrospective study of a random sample of 500 clinical charts of patients with diabetes who attended the Retina Service of ªFundación CODET para la Prevención de la Ceguera IBPº Ophthalmologic Center between 2006 and 2010. Results: The main complaint of 58% of patients was decreased visual acuity in first evaluation. Only 6.2% of patients were referred by a health professional. Forty-six percent of the patients had a history of diabetes of at least 15 years. Thirty percent had clinically significant visual impairment at first visit, which was associated with a long history of diabetes and previous eye surgery. Twenty-five percent of these patients who were treated at our clinic experienced visual deterioration due to advanced retinopathy. Conclusion: Patients with diabetic retinopathy are referred to ophthalmological service tardily, when visual loss is usually severe and irreversible.


REFERENCES

  1. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14 Suppl 5:S1-85.

  2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-53.

  3. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year 2010. Diabetes Res Clin Pract. 2010;87(1):15-9.

  4. van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17 Suppl 1:S3-8.

  5. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21(9):1414-31.

  6. Unwin N, Whiting D, Gan D, Jacqmain I, Ghyoot G. The diabetes atlas. 4.a ed. Bélgica: International Diabetes Federation; 2009.

  7. Olaiz-Fernández G, Rivera-Dommarco J, Shamah-Levy T, et al. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca: Instituto Nacional de Salud Pública; 2006.

  8. Olaiz-Fernández G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S. Diabetes mellitus en adultos mexicanos. Resultados de la Encuesta Nacional de Salud 2000. Salud Pública Mex. 2007;47(Suppl 3):S331-7.

  9. Rodríguez-Bolaños RA, Reynales-Shigematsu LM, Jiménez-Ruiz JA, Juárez-Márquez SA, Hernández-Ávila M. Costos directos de atención médica en pacientes con diabetes mellitus tipo 2 en México: análisis de microcosteo. Rev Panam Salud Pública. 2010;28(10):412-20.

  10. Barceló A, Aedo C, Rajpathak S, Robles S. The cost of diabetes in Latin America and the Caribbean. Bulletin of the World Health Organization. 2003;81(1):19-27.

  11. Arredondo A, Icaza E. Financial requirements for the treatment of diabetes in Latin America: implications for the health system and for patients in México. Diabetologia. 2009;52(8):1693-5.

  12. Arredondo A, Zuñiga A. Economic consequences of epidemiological changes in diabetes in middle-income countries. The mexican case. Diabetes Care. 2004;27(1):104-9.

  13. Arredondo A, Zúñiga A, Parada I. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico. Public Health. 2005;119(8):711-20.

  14. Barría-von-Bischhoffshausen F, Martínez-Castro F. Guía práctica clínica de retinopatía diabética para latinoamérica. Querétaro, México: Asociación Panamericana de Oftalmología. Sub-comité de Retinopatía Diabética del programa Visión 2020LA de la Agencia Internacional para la Prevención de la Ceguera; 2011.

  15. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. III Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthlamol. 1984;102(4):527-32.

  16. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthlamol. 1984;102(4):520-6.

  17. Zhang X, Saaddine JB, Chou C-F, et al. Prevalence fo diabetic retinopathy in the United States, 2005-2008. JAMA. 2010;304(6):649-56.

  18. Carrillo-Alarcón LC, López-López E, Hernández-Aguilar C, Martínez-Cervantes JA. Prevalencia de retinopatía diabética en pacientes con diabetes mellitus tipo 2 en Hidalgo, México. Rev Mex Oftalmol. 2011;85(3):142-7.

  19. Rodríguez-Villalobos E, Cervantes-Aguayo F, Vargas-Salcido E, Ávalos- Muñoz ME, Juárez-Becerril DM, Ramírez-Barba EJ. Retinopatía diabética. Incidencia y progresión a 12 años. Cir Ciruj. 2005;73(2):79-84.

  20. Bustos-Saldaña R, Barajas-Martínez A, López-Hernández H, Sánchez- Novoa E, Palomera-Palacios R, Islas-García J. Conocimientos sobre diabetes mellitus en pacientes diabéticos tipo 2 tanto urbanos como rurales del occidente de México. Archivos en Medicina Familiar. 2007;9(3):147-59.

  21. Garza-Elizondo ME, Villarreal-Rios E, Salinas-Martínez AM, Núñez-Rocha GM. Prácticas preventivas de los habitantes mayores dde 25 años en Monterrey y su zona metropolitana (México). Rev Esp Salud Pública. 2004;78(1):95-105.

  22. Pérez-Cuevas R, Reyes-Morales H, Flores-Hernández S, Wacher-Rodarte N. Efecto de una guía de práctica clínica para el manejo de la diabetes tipo 2. Rev Med Inst Mex Seguro Soc. 2007;45(4):353-60.

  23. Salinas-Martínez AM, Muñoz-Moreno F, Barraza-León AR, Villarreal-Ríos E, Muñoz-Rocha GM, Garza-Elizondo ME. Necesidades en salud del diabético usuario del primer nivel de atención. Salud Pública Mex. 2001;43(4):324-35.

  24. Dandona L, Dandona R. Revision of visual impairment definitions in the International Statistical Classification of Diseases. BMC Medicine. 2006;4:1-7.

  25. Norma Oficial Mexicana para la Prevención, Tratamiento y Control de la Diabetes Mellitus. NOM 174-SSA2-2010. México, D.F.: Diario Oficial de la Federación. Secretaría de Gobernación; 2010.

  26. Prado-Serrano A, Guido-Jiménez MA, Camas-Benítez JT. Prevalencia de retinopatía diabética en población mexicana. Rev Mex Oftalmol. 2009; 83(5):261-6.




2020     |     www.medigraphic.com